Современный взгляд на лучевую терапию в сочетании с мастэктомией в комплексном лечении рака молочной железы

Современный взгляд на лучевую терапию в сочетании с мастэктомией в комплексном лечении рака молочной железы

Автор: Понкратова Юлия Анатольевна

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Обзоры

Статья в выпуске: 3 т.11, 2011 года.

Бесплатный доступ

В статье представлена информация относительно современного состояния проблемы использования лучевой терапии при лечении местно-распространенного рака молочной железы в сочетании с хирургическим и системным лечением.

Рак молочной железы, дозы, осложнения, мастэктомия

Короткий адрес: https://sciup.org/14955265

IDR: 14955265

Список литературы Современный взгляд на лучевую терапию в сочетании с мастэктомией в комплексном лечении рака молочной железы

  • Overgaard M., Hansen P.S., Overgaard J., et al.Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group82b Trial//N Engl J Med. 1997. № 337 (14). Р. 949-955.
  • Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial.//Lancet. 1999. № 353 (9165). Р. 1641-1648.
  • Ragaz J., Jackson S.M., Le N., et al.Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.//N Engl J Med. 1997. №337(14). Р. 956-962.
  • Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patient with high-risk breast-cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.//J Natl Cancer Inst. 2005. №97(2). Р. 116-126.
  • Papaioannou A., Lissaios B., Vasilaros S., et al. Pre-and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancer//Cancer. 1983. V.51(7).P.1284-90.
  • Хмелевский Е.В. Современная лучевая терапия в лечении местнораспространенного и рецидивирующего рака молочной железы: Диссертация на соискание степени доктора медицинских наук./РНЦРР. Москва. 1997.
  • El-Tamer M, Homel P, Braverman AS. Radiotherapy and chemotherapy in high-risk breast cancer.//N Engl J Med. 1998. 338(5). Р.329
  • Goldhirch A., Coates A.S., Cjlleoni M., Gelber R.D. Radiotherapy and chemotherapy in high-risk breast cancer.//N Engl J Med. 1998. №338(5). Р. 330-331.
  • Early Breast Cancer Trialists' Collaborative Group. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials.//Lancet. 2000. №355(9217). Р. 1757-1770.
  • Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: аn overview of the randomized trials.//N Engl J Med. 1995. №333(22). 1444-55.
  • Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials.//Lancet. 2005. №366(9503). Р. 2087-2106.
  • Nielsen H.M., Overgaard M., Grau C. et al. Overgaard Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.//J Clin Oncol. 2006. №24(15). Р. 2268-2275.
  • Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials//J Clin Oncol. 2006. №24(13). Р. 2028-2037.
  • Elkhuizen PH, Hermans J, Leer JW, van d EVML. Isolated late local recurrence with high mitotic count and early local recurrences following breast-conserving therapy are assotiated with increased risk on distant metastasis.//Int J Radiat Oncol Biol Phys. 2001.№50(2). Р.387-396.
  • Haffty B.G., Reiss M., Beinfield M., et al. I psilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse.//J Clin Oncol. 1996. №14(1). Р. 52-57.
  • Meric F., Mirza N.Q., Vlastos G., et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.//Cancer. 2003. №97(4). Р.926-933.
  • Vicini F.A., Kestin L., Huang R., Martinez A. Does local recurrence affect the rate of distant metastasis and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?//Cancer. 2003. №97(4). Р. 910-919.
  • Whelan T., Clark R., Roberts R., et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.//Int J Radiat Oncol Biol Phys. 1994. №30(1). Р. 11-16.
  • Smith T.E., Lee D., Carter D., Haffty B.G. True recurrence vs new primary ipsilateral breast tumor relapse:an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management.//Int J Radiat Oncol Biol Phys. 2000. №48(5). Р. 1281-1289.
  • Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors.//Am J Clin Pathol. 2005. №123(5). Р.679-689.
  • Harris JR, Lipman ME, Morrow M, et al. Diseases of the breast. -Philadelphia. 2004.
  • Хмелевский Е.В., Паньшин Г.А., Шишкин А.М. Повышает ли предоперационная лучевая терапия риск диссеминации при раке молочной железы?//3-я ежегодная Российская онкологическая конференция. С.Пб. 1999. с.98
  • Харченко В.П., Хмелевский Е.В., Чхиквадзе В.Д., и др. Особенности развития и факторы риска постмастэктомических местно-регионарных рецидивов рака молочной железы.//Вопросы онкологии. 2009. том 55. №4. с 11.
  • Buchholz T.A., Austin-Seymour M.M., Moe R.E., et al. Effect of delay in radiation in the combined modality treatment of breast cancer//Int J Radiat Oncol Biol Phys. 1993. V.26(1). P.23-35.
  • Харченко В.П., Рожкова Н.И. Маммология. Национальное руководство. -Москва. Геотар-Медиа.2009. с. 257-8.
  • Olivitto I.A. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials.//Lancet 2005. №365(9472). Р.1687-717.
  • Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy,or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter and less.//J Clin Oncol. 2002. №20(20). Р.4141-9.
  • Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer.//N Engl J Med. 2004. №351(10). Р.963-70.
  • Spangenberg JP, Nel CJ, Anderson JD, Doman MJ. A prospective study of the treatment of stage III breast cancer.//S Afr J Surg. 1986. Vol.Jun;24(2). P.57-60.
  • Recht A, Come SE, Craig Henderson I et al. The sequencing of chemotherapy and radiotherapy after conservative surgery for early-stage breast cancer.//N Engl J Med. 1996. №334. Р.1356-61.
  • Bellon JR, Come SE, Gelman RS, et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.//J Clin Oncol. 2005. № Mar 20;23(9). Р.1934-40.
  • Piroth MD, Pinkawa M, Gagel B, et al. Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy -a retrospective analysis.//BMC Cancer. 2008. Apr 23. Р. 114.
  • Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guigelines of the American Society of Clinical Oncology.//J Clin Oncol. 2001. V.19(5)/P.1539-69.
  • Gnant M, Harbeck N, Thomssen C./St. Gallen 2011: Summary of the Consensus Discussion//Breast Care (Basel). 2011.V.6(2).P.136-141.
  • Kunkler I.H., Price A., Dixon M., et al. SUPREMO (Selective Use of Postoperative Radiotherapy after Mastectomy) -a phase III randomized trial assessing the role of postmastectomy chest wall irradiation in "intermediate risk" women with operable breast cancer receiving adjuvant systemic therapy.//International congress of radiation research. Brisbane, Australia, 2003. Р. 1159.
  • Truong P.T., Chua B. Postmastectomy radiation therapy: who needs it?//J Clin Oncol. 2004. №22(21). Р. 4237-4239.
  • Recht A., Gray R., Davidson N.E., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of Eastern Cooperative Oncology Group.//J Cln Oncol. 1999. №17(6). Р. 1689-1700.
  • Katz A., Strom E.A., Buchholz T.A., et al. The influence of pathologic tumor characteristic on locoregional recurrence rates following mastectomy.//Int J Radiat Oncol Biol Phys. 2001. №50(3). Р. 735-742.
  • Wallgren A., Bonetti M., Gelber R.D., et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.//J Clin Oncol. 2003. №. 21(17). Р. 1205-1213.
  • Truong P.T., Olivotto I.A., Kader H.A., et al. Selecting breast cancer patients with T1-2 tumors and one to three positive axillary nodes at high postmastectomy locoregional risk for adjuvant radiotherapy.//Int J Radiat Oncol Biol Phys. 2005. №61(5). Р. 1337-1347.
  • Truong P.T., Olivotto I.A., Speers C.H., et al. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.//Int J Radiat Oncol Biol Phys. 2004. №58(3). Р. 797-804.
  • Huang E.H., Tucker S.L., Strom E.A., et al. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy and radiotherapy.//Int J Radiat Oncol Biol Phys. 2005. №62. Р. 351-7.
  • Huang E.H., Strom E.A., Perkins G.H., et al. Comparison of risk of locoregional recurrence after mastectomy or breast concervation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to prognostic index score.//Int J Radiat Oncol Biol Phys. 2006. №66(2). Р. 352-357.
  • Truong P.T., Berthelet E., Lee J.,. et al. The prognostic significance of the percentage of positive\dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.//Cancer. 2005. №103(10). Р. 2006-2014.
  • Cheng J.C., Chen C.M., Liu M.C., et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.//Int J Radiat Oncol Biol Phys. 2002. №52(4). Р. 980-988.
  • Katz A., Strom E.A., Buchholz T.A., et al. The influence of pathologic tumor characteristic on locoregional recurrence rates following mastectomy.//Int J Radiat Oncol Biol Phys. 2001. №50(3). Р. 735-742.
  • Recht A., Gray R., Davidson N.E., et al.Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of Eastern Cooperative Oncology Group.//J Clin Oncol. 1999. №17(6). Р. 1689-1700.
  • Ragaz J., Jackson S M. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.//Cancer. 2000. №89(1). Р. 223-225.
  • Truong P.T., Yong C.M., Abnoursi F., et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.//J Am Coll Surg. 2005. №200(6). Р. 912-921.
  • Schoppmann S.F., Bayer G., Aumayr K., et al. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.//Ann Surg. 2004. №240(2). Р. 306-312.
  • Pinder S.E., Ellis I.O., Galea M., et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up.//Histopathology. 1994. №24(1). Р. 41-47.
  • Hasebe T., Sasaki S., Imoto S., Ochiai A. Histological characteristic of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast: a prospective study.//Hum Pathol. 2004. №35(3). Р. 298-308.
  • Goldhirsch A., Glick J.H., Gelber R.D., et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.//Ann Oncol. 2005. №16(10). Р. 1569-1583.
  • Weigelt B., Hu Z., He X., et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer//Cancer Res. 2005. №65. Р. 9155-9158.
  • Bender R.A., Knauer M., Rutgers E.J., et al.The 70-gene profile and chemotherapy benefit in 1600 breast cancer patients.//J Clin Oncol. 2009. №27(suppl 15s). Abstract 512.
  • Jerevall PL,Brommesson P.L., Strand C., et al. Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL 17BR in prediction of clinical outcome//Breast Cancer Res Treat. 2008. №107. Р. 225-234.
  • Ma X.J., Hilsenback S.G., Wang W., et al. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.//J Clin Oncol. 2006. №24. Р. 4611-4617.
  • Dowsett M., Cuzick J., Wales C., et al. Risk of distant recurrence using oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.//Cancer Res. 2009. №69(suppl). Abstract 53.
  • Kreike B., Halfwerk H., Armstrong N., et al. Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients.//Clin Cancer Res. 2009. №15(12). Р. 4181-4190.
  • Nuyten D.S., Hastie T., Chi J.T., et al. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification//Eur J Cancer. 2008.44(15).P.2319-29.
  • Early Breast Cancer Trialists' Collaborative Group (EBCTCG)//Lancet. 2005. Vol. 366. Р. 2087-106.
  • Giordano S.H., Kuo Y.F., Freeman J.L., et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer.//J Natl Cancer Inst. 2005. №16;97(6). Р. 419-424.
  • Lind P., Rosfors S., Wennberg В., et al. Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimentional treatment planning.//Radiother Oncol. 1998. V.49. P.245-254.
  • Байсоголов Г.Д. Актуальные проблемы лучевой терапии//Медицинская радиология. 1987. №3. С.3-6.
  • Байсоголов Г.Д., Кирюшкин В.И. Результаты электрокардиографического обследования больных хронической лучевой болезнью.//Бюллетень радиационной медицины. 1961.№4. С.143-150.
  • Байсоголов Г.Д., Кирюшкин В.И. Состояние сердечной мышцы у больных хронической лучевой болезнью в различные периоды заболевания (по данным эхокардиографического исследования). -Радиация и риск. Обнинск. 2000. С.43-47.
  • Иваницкая В.И., Кисличенко В.А., Геринштейн И.Г. и др. Осложнения лучевой терапии у онкологических больных.//Здоровье. Киев, 1989 С. 181.
  • Корытников В.И., Эттингер Т.С., Проскурина Т.В. Изменения сердца, обусловленные отдаленными последствиями лучевой терапии.//Клиническая медицина. 1999. №11. С. 52-55.
  • Gagliardi G., Ingmar Lax., Gabor G. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer.//Radiotherapy and oncology. 1998. Vol 46 (1). Р. 63-71.
  • Girinsky T., Cosset J.M. Pulmonary and cardiac late effects of ionizing radiations alone or combined with chemotherapy.//Cancer Radiotherapy. 1997. Vol 1(6). Р. 43-735
  • Сергоманова Н.Н. Постлучевые изменения сердечно-сосудистой системы при комплексном лечении рака молочной железы: Диссертация на соискание ученой степени кандидата медицинских наук/РНЦРР. Москва. 2005.
  • Хмелевский Е.В., Добренький М.Н., Сергоманова Н.Н. и др. Факторы риска постлучевых повреждений у больных раком молочной железы.//Вестник РНЦРР. №5. 2005. С. 42-45.
  • Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries.//Lancet Oncol. 2005. №6(8). Р. 557-565.
  • McGale P., Darby S.C. Commentary: A dose-response relationship for radiation-induced heart disease-current issues and future prospects.//Int J Epidemiol. 2008. №37(3). Р.518-523.
  • Patt D.A., Goodwin J.S., Kuo Y.F., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer.//J Clin Oncol. 2005. №20;23(30). Р. 7475-7482.
  • Dewar J.A., Haviland J.S., Agrawal R.K. et al.//START trials. 2007. Vol. 25. -LBA518.
Еще
Статья обзорная
SciUp 2024 © 2024 ©